CARACAS, April 9 (Xinhua) -- Venezuelan President Nicolas Maduro on Tuesday met with his Colombian counterpart Gustavo Petro here to discuss bilateral relations.
"Nothing and no one will separate us from Colombia ... We have great goals to achieve: making progress in economy, in trade and in peace," the Venezuelan president said on social media platform X.
The two nations have "many things to deepen: energy projects, gas, oil, border security, among other issues and common points that are above our differences," he added.
Venezuelan Foreign Affairs Minister Yvan Gil received the Colombian president at the Simon Bolivar International Airport.
Gil posted on X, "we welcome Colombian President Gustavo Petro back to our country, with whom we have an important common agenda for the good of our peoples and the region. Fraternity and peaceful diplomacy continue to triumph."
Venezuela severed political and diplomatic ties with Colombia on Feb. 23, 2019, after the neighboring nation, under U.S. pressure, recognized Venezuela's opposition leader Juan Guaido as interim president instead of the mandate of President Maduro.
The two countries resumed diplomatic relations in August 2022. ■
Chinese military ready to boost ties with Indonesian counterpart: defense spokesperson
Confusion about brand name leads to false claims about Aldi’s bacon
A new declaration in Mexico gives 19 cats roaming the presidential palace food and care fur
Federal data does not show a soaring number of unauthorized migrants registering to vote
Queen Camilla appears in high spirits as she hosts the first female crew to win an around
Uyghur activist receives Roosevelt freedom of worship award — Radio Free Asia
Coalition's first budget to be unveiled on 30 May
Intuitive Machines: Odysseus Moon lander 'tipped over on touchdown'
Tigers and Cardinals rained out, will play a traditional doubleheader on Tuesday
Shoplifter chased by police on horses in New Mexico, video shows
Emily Henry interview: The secret to having a healthy relationship with love
Study: Many cancer drugs unproven 5 years after accelerated approval